Merck&Co earnings beat by $0.18, revenue topped estimates


Add to/Remove from Watchlist

Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio - Merck&Co (NYSE: MRK) reported third quarter EPS of $2.13, $0.18 better than the analyst estimate of $1.95. Revenue for the quarter came in at $16B versus the consensus estimate of $15.29B.


Merck&Co sees FY 2023 EPS of $3.03-$3.08 versus the analyst consensus of $2.86.

Merck&Co sees FY 2023 revenue of $59.70B-$60.20B versus the analyst consensus of $55.98B.

Merck&Co's stock price closed at $103.63. It is down -2.55% in the last 3 months and up 3.90% in the last 12 months.

Merck&Co saw 7 positive EPS revisions and 10 negative EPS revisions in the last 90 days. See Merck&Co's stock price’s past reactions to earnings here.

According to InvestingPro, Merck&Co's Financial Health score is "great performance".

Check out Merck&Co's recent earnings performance, and Merck&Co's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting's earnings calendar

Leave a Reply

Your email address will not be published. Required fields are marked *


Sam Bankman-Fried has no way to ‘outfox’ prosecutors: Scaramucci


LedgerX highlights CFTC regulatory gap in customer asset rules